User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 15 results.
    • Speech
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.
    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1997) —
    • Speech
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.
    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
    • Speech
    Rituximab given after high dose therapy and autologous stem cell transplantation induces durable clearance of minimal residual disease in about half of the patients with follicular non Hodgkin's lymphoma: 36 months results of a multicenter open label phase II trial (M39012 trial).
    Morschhauser, F. Recher, C. Milpied, N. Gressin, R Salles, G. Brice, P. Vey, N Haioun, C. Colombat, P Bourhis, JH Rossi, JF Berriot-Varoqueaux, N Bergougnoux, L Bosly, André[UCL] Delsol, G. Attal, M. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Speech
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93
    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
    • Journal article
    Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
    Bachy, E. Houot, R. Morschhauser, F. Sonet, Anne[UCL] Brice, P. Belhadj, K. Cartron, G. Audhuy, B. Fermé, C. Feugier, P. Sebban, C. Delwail, V. Maisonneuve, H. Le Gouill, S. Lefort, S. Brousse, N. Foussard, C. Salles, G. (2013) Haematologica : journal of hematology — Vol. 98, no.7, p. 1107-1114 (2013)
    • Journal article
    Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis
    Xerri, L. Bachy, E. Fabiani, B. Canioni, D. Chassagne-Clément, C. Dartigues-Cuilléres, P. Charlotte, F. Brousse, N. Rousselet, M.-C. Foussard, C. Brice, P. Feugier, P. Morschhauser, F. Sonet, Anne[UCL] Olive, D. Salles, G. (2014) Human Pathology — Vol. 45, no.10, p. 2085-2093 (2014)
    • Journal article
    Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): A randomised phase 3 trial
    Delarue, R. Tilly, H. Mounier, N. Petrella, T. Salles, G. Thieblemont, C. Bologna, S. Ghesquières, H. Hacini, M. Fruchart, C. Ysebaert, L. Fermé, C. Casasnovas, O. Van Hoof, A. Thyss, A. Delmer, A. Fitoussi, O. Molina, T.J. Haioun, C. Bosly, André[UCL] (2013) The Lancet Oncology — Vol. 14, no.6, p. 525-533 (2013)
    • Journal article
    Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: Results of the prospective multicenter H96 trial by the GELA/SFGM study group
    Morschhauser, F. Brice, P. Fermé, C. Diviné, M. Salles, G. Bouabdallah, R. Sebban, C. Voillat, L. Casasnovas, O. Stamatoullas, A. Bouabdallah, K. André, Marc Jais, J.-P. Cazals-Hatem, D. Gisselbrecht, C. (2008) Journal of Clinical Oncology — Vol. 26, no.36, p. 5980-5987 (2008)
    • Speech
    Bone-marrow Transplantation Prolongs Survival After Relapse in Lymphoma Patients - Long-term Follow-up
    Bosly, André[UCL] Coiffier, B. Tilly, H. Herbrecht, R. Legros, M. Sebban, C. Simon, M. Salles, G. Martiat, P. Jaubert, J. Gisselbrecht, C. (1993) —
    • Speech
    Long term results of the GELA study, R-CHOP vs. CHOP in elderly patients with diffuse large B-cell lymphoma.
    Coiffier, B. Feugier, P Sebban, C. Bouabdallah, R. Delwail, V Tilly, H. Gisselbrecht, C. Bosly, André[UCL] Salles, G. Reyes, F. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Journal article
    Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial
    Mounier, N. El Gnaoui, T. Tilly, H. Canioni, D. Sebban, C. Casasnovas, R.-O. Delarue, R. Sonet, Anne[UCL] Beaussart, P. Petrella, T. Castaigne, S. Bologna, S. Salles, G. Rahmouni, A. Gaulard, P. Haioun, C. (2013) Haematologica : journal of hematology — Vol. 98, no.11, p. 1726-1731 (2013)
    • Journal article
    Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study
    Haioun, C. Lepage, E. Gisselbrecht, C. Salles, G. Coiffier, B. Brice, P. Bosly, André[UCL] Morel, Priscilla[UCL] Nouvel, C. Tilly, H. Lederlin, P. Sebban, C. Briere, J Gaulard, P. Reyes, F. (2000) Journal of Clinical Oncology — Vol. 18, no. 16, p. 3025-3030 (2000)
    • Speech
    Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.
    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Coiffier, B. (1997) —
    • Journal article
    Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe d'Etude des lymphomes de l'adulte
    Feugier, P Van Hoof, A. Sebban, C. Solal-Celigny, P. Bouabdallah, R. Ferme, C Christian, B. Lepage, E. Tilly, H. Morschhauser, F. Gaulard, P. Salles, G. Bosly, André[UCL] Gisselbrecht, C. Reyes, F. Coiffier, B. (2005) Journal of Clinical Oncology — Vol. 23, no. 18, p. 4117-4126 (2005)
    • Speech
    Long Term Follow-up of the GELF86 French and Belgian Trials : Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission.
    Bachy, E. Brice, P. Fournier, M. Tilly, H. Haioun, C. Brousse, N. Le Gouil, S. Bosly, André[UCL] Coiffier, B. Gisselbrecht, C. Solal-Celigny, P. Salles, G. (2008) 50th Annual Meeting of the American- Society-of-Hematology — San Francisco(Ca)